FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
Greg Rosenfeld(British Columbia Centre on Substance Use), Brian Bressler(University of British Columbia), Andrew M. Round(Brunel University of London), Lawrence Halparin(University of British Columbia), Abid Saadeddin(University of British Columbia), Terry Lee(Janssen (Belgium)), Astrid-Jane Greenup(University of British Columbia), Oliver Takach(University of British Columbia), Jin Kee Ho(University of British Columbia), Robert Enns(University of British Columbia)
Cited by 12
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478